Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.02, from 0.94 in 2017Q2. It improved, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. America First Limited Liability stated it has 0% in Pfizer Inc. (NYSE:PFE). 10,826 were accumulated by Clark Management Grp Inc. Peapack Gladstone holds 0.42% of its portfolio in Pfizer Inc. (NYSE:PFE) for 203,467 shares. 359,000 are owned by Caledonia Invs Public Ltd Co. Signalpoint Asset Management Limited Liability invested in 0.21% or 11,651 shares. Jolley Asset Management Ltd Com invested 2.99% in Pfizer Inc. (NYSE:PFE). Cetera Advsr Ltd Llc holds 0.23% or 105,152 shares. Partner Mngmt Ltd Partnership holds 1.05% or 31,061 shares. Northside Cap Mgmt Limited Com reported 12,150 shares. Old Natl Retail Bank In reported 292,945 shares or 0.57% of all its holdings. 137,999 were accumulated by Woodley Farra Manion Management. Steinberg Global Asset Management reported 200,381 shares. Cadence Commercial Bank Na has invested 1.33% in Pfizer Inc. (NYSE:PFE). Tci Wealth Advsrs accumulated 1.22% or 69,909 shares. Ssi Incorporated holds 0.08% of its portfolio in Pfizer Inc. (NYSE:PFE) for 25,195 shares.
Since August 4, 2017, it had 0 insider purchases, and 10 selling transactions for $16.36 million activity. Shares for $249,900 were sold by MACKENZIE ALEXANDER R. Shares for $3.21 million were sold by DAMELIO FRANK A. JOHNSON RADY A sold $296,560 worth of stock or 8,000 shares. READ IAN C had sold 96,950 shares worth $3.30 million on Friday, August 4. OLSON LAURIE J sold $263,693 worth of stock or 8,064 shares.
Hgk Asset Management Inc increased its stake in Pfizer Inc. (PFE) by 55.68% based on its latest 2017Q3 regulatory filing with the SEC. Hgk Asset Management Inc bought 151,117 shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 422,536 shares of the health care company at the end of 2017Q3, valued at $15.09 million, up from 271,419 at the end of the previous reported quarter. Hgk Asset Management Inc who had been investing in Pfizer Inc. for a number of months, seems to be bullish on the $215.42B market cap company. The stock decreased 0.28% or $0.1 during the last trading session, reaching $36.14. About 8.60M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since December 25, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.
Hgk Asset Management Inc, which manages about $4.73 billion and $703.78M US Long portfolio, decreased its stake in State Street Corp. (NYSE:STT) by 35,515 shares to 170,298 shares, valued at $16.27M in 2017Q3, according to the filing. It also reduced its holding in Unitedhealth Group (NYSE:UNH) by 16,015 shares in the quarter, leaving it with 75,456 shares, and cut its stake in Citigroup Inc. (NYSE:C).
More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Chicagotribune.com which released: “Viagra goes generic: Pfizer to launch own little white pill” on December 06, 2017, also Businesswire.com with their article: “Pfizer Inc. Announces Pricing and Early Results of its Tender Offer for its 5 …” published on December 21, 2017, Seekingalpha.com published: “Pfizer Giving You A Raise” on December 21, 2017. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Investorplace.com and their article: “Why Owning Pfizer Inc. Stock Is Little Better Than Cash” published on December 21, 2017 as well as Businesswire.com‘s news article titled: “Pfizer Inc. Announces Expiration and Results of its Private Exchange Offer for …” with publication date: December 15, 2017.
Pfizer Inc. (NYSE:PFE) Ratings Coverage
Among 21 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Pfizer had 67 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Tuesday, November 21 by BMO Capital Markets. The company was maintained on Saturday, September 5 by Piper Jaffray. The stock has “Hold” rating by S&P Research on Wednesday, October 28. Cowen & Co maintained the shares of PFE in report on Monday, August 14 with “Buy” rating. The rating was downgraded by Credit Suisse on Thursday, July 20 to “Neutral”. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) on Thursday, October 19 with “Outperform” rating. The firm has “Equal-Weight” rating given on Tuesday, December 1 by Barclays Capital. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Piper Jaffray on Wednesday, August 2. The firm earned “Overweight” rating on Tuesday, November 29 by Barclays Capital. Jefferies maintained the stock with “Hold” rating in Monday, October 16 report.